My watch list  

15 Current news of Accelrys


You can refine your search further. Select from the filter options on the left to narrow down your results.

Accelrys, Inc. Names Max Carnecchia To Serve As Chief Executive Officer And President


Accelrys, Inc. announced that its Board of Directors has named Scipio “Max” Carnecchia to serve as the Company’s Chief Executive Officer and President. Mr. Carnecchia has also been appointed to the Company’s Board of Directors. Mr. Carnecchia comes to Accelrys with more than two decades of high ...


Accelrys, Johnson Matthey and CMR Form Consortium for Alternative Energy Research

Fuel Cell Consortium Result of Award from United Kingdom's Department of Trade and Industry (DTI) for the Automated Design of New Materials for Fuel Cell Catalysts


Accelrys, Inc. together with CMR Fuel Cells and Johnson Matthey Plc, announced the formation of a UK-based Research Consortium. Funding has been awarded through DTI's Technology Programme competition. The DTI will award the Consortium a total of GBP 1.15 million over the duration of the ...


Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium

Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture


Accelrys, Inc. announced the addition of Pfizer to the Accelrys Enterprise Cheminformatics Consortium. The Consortium will be a collaborative software development project led by Accelrys in partnership with a group of commercial member organizations. Its goal is to prioritize, design, and develop ...


Accelrys Nanotechnology Consortium Adds Seven Members, Delivers First Computer-Aided Nanodesign Software Solution


Accelrys, Inc. announced the addition of seven new members to the Accelrys Nanotechnology Consortium, as well as the introduction of ONETEP, the first consortium-developed software application. The Consortium brings together leaders from industry, government and academia in order to create ...


SciTegic Announces Expanded Commitment to Pipeline Pilot at Unileve


SciTegic, Inc., a wholly owned subsidiary of Accelrys, Inc., announced the sale of a multi-year license of Pipeline Pilot software to Unilever. SciTegic's data pipelining platform is now deployed at four Unilever sites across Europe and the U.S. Unilever is using Pipeline Pilot widely, primarily ...


Accelrys Opens New UK Headquarters

New Facility to Serve as Base for European Operations


SAN DIEGO, July 19 - Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc, today announces the opening of its new European headquarters in Cambridge, England. The headquarters will be the base for Accelrys' European operations, and will provide services, support and training to its UK ...


Accelrys launches first series of Discovery Studio applications

Major milestone reached in effort to deliver an integrated informatics, modeling and simulation platform to speed pharmaceutical discovery


San Diego, CA, June 26 2002 Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc., today announced the first suite of Windows®-based bioinformatics and chemistry applications for its Discovery Studio™ platform. Discovery Studio is designed as a fully integrated enterprise platform to ...


Personal Chemistry and Accelrys enter into software licensing agreement and technology alliance


San Diego, CA, May 23 2002 Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. and Personal Chemistry, a private Swedish company, today announced the signing of a software licensing agreement and technology alliance. Under the terms of the agreement, Accelrys will license the use of ...


Accelrys announces the release of software für efficient processing and analysis of NMR (nuclear magnetic resonance)


San Diego, CA, Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc., announces the release of FELIX Desktop 2002, the new PC version of FELIX. FELIX is a widely used software package for off-line data processing, spectral visualization and analysis software for all types of high ...




Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), today announced the release of TOPKAT BATCH and Version 6.1 of TOPKAT, a leading program for the in silico estimation of toxicological properties of small molecules destined for use as therapeutics, agrochemical ...


Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE